Greetings and welcome to the First Quarter 2020 Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we'll conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded Wednesday, May 6, 2020. I would now like to turn the conference over to Kevin Karas, Chief Financial Officer. Please go ahead.

Thank you, Kelly. And welcome everyone to National Research Corporation's 2020 first quarter earnings call. My name is Kevin Karas, the Company's Chief Financial Officer. I'll be handling the call myself today from my home like many of you. Before continuing, I'd like to review conditions related to any forward-looking statements that may be made as part of today's call. This conference call includes forward-looking statements related to the Company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the Company's future results, please see the Company's filings with the Securities and Exchange Commission. Before reviewing first quarter performance, I would like on behalf of all NRC associates to extend a heartfelt thank you to our customers and frontline caregivers around the world for working tirelessly to save lives and keep community safe during the COVID-19 pandemic. As we are all aware, this public health crisis is likely to have an extended financial impact on most sectors of the economy and healthcare is no exception. We have no unique perspective, which will allow us to forecast the depth, duration or specific impact on our clients or the Company and we'll refrain on this in future communication with investors from speculating. Given this uncertainty, our only assumption is that the Company's sales, revenue and margin expansion are unlikely to follow the growth trends of the past. Regarding the facts of our first quarter performance, recurring contract value at the end of the first quarter 2020 ended at $140.4 million, representing an 11% growth over the same period last year. Health care system…

Okay. Thank you, Kelly. In closing, I would just like to say until our next call, our thoughts and support are with those who are on the front lines battling this pandemic. Thank you for your time today.

That does occlude the conference call for today. We thank you for your participation and we ask that you please disconnect your line.